Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Ophthalmology

Understanding Your Eye Freckle: Conjunctival Nevus

At a Glance

A conjunctival nevus is an almost always harmless eye freckle on the membrane covering the white of the eye. Most remain stable and are monitored with photographs and eye examinations; rapid growth, darkening, or new blood vessels should be reviewed by an eye specialist.

Discovering a new spot on your eye can be an alarming experience. However, most of these spots are what eye doctors call a conjunctival nevus, which is essentially a benign (non-cancerous) “eye freckle” [1]. It is a collection of melanocytes (pigment-producing cells) located on the conjunctiva, the clear, thin membrane that covers the white part of your eye [1][2].

These lesions are very common in clinical practice, though exact numbers depend on the study population [1]. While the sight of a pigmented spot on the eye often triggers anxiety, it is important to know that these are almost always harmless and the risk of them becoming a serious health issue is extremely low [1].

Who Gets an Eye Freckle?

Conjunctival nevi are most commonly identified during childhood, adolescence, or early adulthood [1]. They appear with similar frequency in both males and females and are reported across different demographics, though frequently seen in White individuals in clinical series [1].

While they can appear at any age, in some specialized surgical series the average age for someone to have a nevus removed (often for biopsy or cosmetic reasons) is around 28 years old [3]. In some populations, such as Hispanic communities, screening research has found that about 1.3% of people have one of these freckles [4].

Understanding the Biology

A conjunctival nevus is not just a surface stain; it is a stable growth of cells. In some cases, scientists have found that these nevi often contain specific genetic markers, such as BRAF or NRAS mutations [2]. While these terms might sound intimidating because similar pathways can be associated with melanoma, in the context of a stable conjunctival nevus, they are simply part of the “biological signature” of a benign growth [2]. Importantly, molecular findings alone do not establish benignity and are not routine tests for every conjunctival nevus.

One of the most reassuring signs a doctor looks for during an exam is the presence of intralesional cysts [1]. These are tiny, clear bubbles inside the freckle that are highly characteristic of a benign nevus, evaluated directly by the clinician [5].

The Risk of Transformation

The most common concern for patients is whether this freckle will turn into melanoma (a rare but serious form of eye cancer). Research consistently describes this risk as “extremely low” [1].

While some surgical studies have reported higher rates of malignancy, it is crucial to understand that those studies only looked at selected lesions that were already suspicious enough to be cut out [3][6]. For an ordinary, stable freckle that your doctor has identified as a typical nevus, the chance of it changing into cancer is minimal [1][7].

Monitoring and Management

In most cases, the standard of care for a typical conjunctival nevus is “watchful waiting” [1]. This involves:

  • Serial Photography: Your doctor will take high-resolution photos of your eye to use as a baseline for future comparisons [1].
  • Slit-Lamp Examination: A specialized microscope is used to check the margins (edges) and thickness of the spot [1].
  • AS-OCT: In some cases, a non-invasive imaging tool called Anterior-Segment Optical Coherence Tomography (AS-OCT) is used to look at the deeper layers of the lesion without touching the eye [5].

When to Take Action

While most nevi remain stable for a lifetime, your care team will watch for specific “red flags” that might suggest the lesion needs a closer look or a biopsy [8]. Signs that warrant a discussion with an ocular specialist include:

  • Rapid Change: Any sudden increase in size, thickness, or a noticeable darkening of the color [9][10].
  • New Blood Vessels: The appearance of new, prominent “feeder” vessels or internal blood supply within the spot [11].
  • Location: Spots that move onto the cornea (the clear window over the iris) or are located on the underside of the eyelid (the tarsal conjunctiva) may require more frequent monitoring [9].
  • Age of Onset: A pigmented spot that appears for the very first time in an older adult is more likely to be evaluated closely than a spot that has been present since childhood [9].

If you and your doctor decide on removal—whether for medical suspicion or simply because you do not like the look of the spot—the procedure is typically straightforward. Surgeons often use a “no-touch” technique to ensure the area is cleared safely [12][13]. For the vast majority of patients, once a benign nevus is removed, it usually does not recur [14].

Common questions in this guide

What is a conjunctival nevus, or eye freckle?
A conjunctival nevus is a benign collection of pigment-producing cells in the conjunctiva, the thin membrane covering the white of the eye. It is commonly called an eye freckle and is usually stable rather than cancerous.
How likely is an eye freckle to become melanoma?
For a typical, stable conjunctival nevus, the chance of becoming melanoma is extremely low. A spot that grows quickly, thickens, darkens, develops new blood vessels, or appears on the cornea or under the eyelid may need closer evaluation.
How do doctors monitor a conjunctival nevus?
An eye doctor may take baseline and follow-up photographs and examine the spot with a slit lamp, a microscope designed for eye care. Anterior-segment optical coherence tomography, a noninvasive scan, may be used when the doctor needs more information about deeper layers.
When should a conjunctival nevus be checked more closely?
Contact your eye doctor about a rapid change in the spot’s size, thickness, or color, or about new prominent blood vessels. A lesion that extends onto the cornea, lies under the eyelid, or first appears in an older adult may also require closer assessment.
Does every conjunctival nevus need to be removed?
No. Most typical nevi are observed over time, while removal may be considered if the appearance raises concern or for cosmetic reasons. When a benign nevus is removed, it usually does not come back.
What do cysts inside an eye freckle mean?
Tiny clear cysts within a conjunctival nevus are a feature that strongly supports a benign nevus when seen during an eye examination. Their presence helps the clinician interpret the lesion but does not replace regular follow-up when monitoring is recommended.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on conjunctival nevus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my lesion located on the bulbar conjunctiva, and are there intralesional cysts present on examination?
  2. 2.Do you see any signs of intrinsic tumor vasculature or feeder vessels that might indicate activity?
  3. 3.What specific baseline measurements and photographs will you use to monitor this over time?
  4. 4.Does the appearance of this lesion require an anterior-segment OCT (AS-OCT) to help support the diagnosis?
  5. 5.Given my age and the lesion's appearance, what is your recommended schedule for follow-up exams?
  6. 6.Under what specific circumstances would you recommend a biopsy instead of observation?

References

References (14)
  1. 1

    Conjunctival Nevus.

    Huang JJ, Locatelli EVT, Chocron A, et al.

    Current ophthalmology reports 2023; (11(4)):104-112 doi:10.1007/s40135-023-00315-w.

    PMID: 38390435
  2. 2

    BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.

    Francis JH, Grossniklaus HE, Habib LA, et al.

    Investigative ophthalmology & visual science 2018; (59(1)):117-121 doi:10.1167/iovs.17-22517.

    PMID: 29332123
  3. 3

    [Analysis of clinicopathologic characteristics of 422 conjunctival melanocytic nevi specimens].

    Zhang ZB, Liang QF, Huang JJ, Li B

    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2017; (53(8)):583-587 doi:10.3760/cma.j.issn.0412-4081.2017.08.005.

    PMID: 28851198
  4. 4

    Clinical profile of melanocytic lesions of the ocular surface in a Hispanic population.

    Garza-Garza LA, Ramos-Davila EM, Ruiz-Lozano RE, et al.

    International ophthalmology 2022; (42(9)):2765-2772 doi:10.1007/s10792-022-02266-w.

    PMID: 35438422
  5. 5

    Anterior Segment Swept-Source Optical Coherence Tomography in Ocular Surface Tumors and Simulating Lesions and Correlation With Histopathologic Diagnosis.

    Gündüz AK, Mirzayev I, Ersöz CC, et al.

    Cornea 2025; (44(7)):806-818 doi:10.1097/ICO.0000000000003856.

    PMID: 40152549
  6. 6

    Regressing Conjunctival Nevus in a Child.

    Ho VW, Brunner M, Hussain RN, Heimann H

    Journal of ophthalmic & vision research 2018; (13(4)):501-503 doi:10.4103/jovr.jovr_215_17.

    PMID: 30479722
  7. 7

    Melanocytic Nevus of the Tarsal Conjunctiva.

    Yazıcı B, Bilge AD, Yağcı A, et al.

    Balkan medical journal 2016; (33(4)):477-9 doi:10.5152/balkanmedj.2016.150317.

    PMID: 27606149
  8. 8

    [Evaluation of the accuracy of clinical diagnosis of conjunctival neoplasms : Comparison with histological findings after excision].

    Gruben AR, Hösel K, Roider J, Ehlken C

    Die Ophthalmologie 2024; (121(5)):391-396 doi:10.1007/s00347-024-02009-5.

    PMID: 38446196
  9. 9

    A rare case of conjunctival melanoma in an Asian lady: A case report.

    Shandi N, Alkabbani S, Nezzar H

    International journal of surgery case reports 2025; (136()):112061 doi:10.1016/j.ijscr.2025.112061.

    PMID: 41332075
  10. 10

    Conversion of Conjunctival Nevus to Melanoma in a Patient Taking the TYK2 Inhibitor Deucravacitinib.

    Whitcomb N, Lee HJ

    Cornea 2026; (45(1)):105-107 doi:10.1097/ICO.0000000000003942.

    PMID: 40742181
  11. 11

    Indocyanine Green Angiographic Assessment of Conjunctival Melanocytic Disorders.

    Palme C, Wanner A, Romano V, et al.

    Cornea 2021; (40(12)):1519-1524 doi:10.1097/ICO.0000000000002681.

    PMID: 33591034
  12. 12

    Surgical management of a conjunctival nevus with amniotic membrane transplantation.

    Röck T, Bösmüller HC, Bartz-Schmidt KU, Röck D

    International medical case reports journal 2018; (11()):161-165 doi:10.2147/IMCRJ.S164099.

    PMID: 30100765
  13. 13

    Clinical and immunohistopathological study of conjunctival melanocytic lesions in pediatric and adolescent patients. A case series.

    Bogdănici CM, Costea CF, Dumitrescu GF, et al.

    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2021; (62(4)):907-915 doi:10.47162/RJME.62.4.03.

    PMID: 35673810
  14. 14

    Clinicopathologic Characteristics of 40 Cases of Juvenile Conjunctival Nevus.

    Zhao Y, Shi W, Tie Y, et al.

    The American Journal of dermatopathology 2025; (47(4)):287-291 doi:10.1097/DAD.0000000000002921.

    PMID: 39846725

This page about conjunctival nevi is for informational purposes only and does not constitute medical advice. An ophthalmologist should evaluate any new or changing spot on your eye.